Novavax, Inc. (NVAX): Price and Financial Metrics

NVAX POWR Grades

• Value is the dimension where NVAX ranks best; there it ranks ahead of 84.12% of US stocks.
• NVAX's strongest trending metric is Momentum; it's been moving down over the last 48 weeks.
• NVAX ranks lowest in Stability; there it ranks in the 1st percentile.

NVAX Stock Summary

• Of note is the ratio of Novavax Inc's sales and general administrative expense to its total operating expenses; merely 5.04% of US stocks have a lower such ratio.
• In terms of twelve month growth in earnings before interest and taxes, Novavax Inc is reporting a growth rate of 1,060.38%; that's higher than 97.64% of US stocks.
• Revenue growth over the past 12 months for Novavax Inc comes in at 2,252.66%, a number that bests 99.48% of the US stocks we're tracking.
• Stocks with similar financial metrics, market capitalization, and price volatility to Novavax Inc are FIXX, GRTS, OVID, DNLI, and ADVM.
• NVAX's SEC filings can be seen here. And to visit Novavax Inc's official web site, go to www.novavax.com.

NVAX Valuation Summary

• In comparison to the median Healthcare stock, NVAX's price/earnings ratio is 151.23% lower, now standing at -18.7.
• NVAX's price/sales ratio has moved down 7.3 over the prior 243 months.
• NVAX's price/sales ratio has moved down 7.3 over the prior 243 months.

Below are key valuation metrics over time for NVAX.

NVAX Growth Metrics

• Its year over year price growth rate is now at 555.1%.
• Its 5 year net income to common stockholders growth rate is now at -5.16%.
• Its 4 year net cashflow from operations growth rate is now at 34.04%.

Over the past 33 months, NVAX's revenue has gone up $1,143,356,000.

The table below shows NVAX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	1,181.929	672.432	-949.91
2021-03-31	919.45	643.654	-615.114
2020-12-31	475.598	-42.541	-418.259
2020-09-30	204.755	62.284	-272.525
2020-06-30	50.238	36.522	-93.258
2020-03-31	18.057	-109.126	-115.34

NVAX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• NVAX has a Quality Grade of C, ranking ahead of 58.9% of graded US stocks.
• NVAX's asset turnover comes in at 0.6 -- ranking 58th of 677 Pharmaceutical Products stocks.
• GTHX, SRRA, and OPK are the stocks whose asset turnover ratios are most correlated with NVAX.

The table below shows NVAX's key quality metrics over time.